New Report Predicts Sharp Rise in Ascites Cases Due to Cirrhosis, Driving Significant Growth in Ascites Treatment Market
• The ascites market size across 7MM is expected to grow significantly by 2032, with a substantial increase in ascites cases due to cirrhosis
• In 2022 in the US, there were 27K Grade I ascites cases due to cirrhosis, making up 22% of all grade ascites cases
• Key companies like Ocelot Bio, PharmaIN, and Grifols are developing new ascites therapies like OCE-205, PHIN-214, and Albutein 20%
• The rise in underlying conditions and better diagnosis will drive ascites market growth, though high costs and access issues may limit growth
• DelveInsight’s ascites market report covers epidemiology, therapies, key companies, and 7MM ascites market forecasts from 2019-2032